|
US2017043016A1
|
|
Solid Solution Compositions and Use in Severe Pain
|
|
CN108025078A
|
|
Solid solution composition for NSAID
|
|
US2016120899A1
|
|
Drug Combinations and Uses in Treating a Coughing Condition
|
|
US2016101180A1
|
|
Compositions and methods for treating severe pain
|
|
US2016101077A1
|
|
Compositions and methods for treating severe pain
|
|
US2015342880A1
|
|
Solid solution compositions and use in chronic inflammation
|
|
EP3127556A1
|
|
Solid solution compositions for nsaid
|
|
AU2015201845A1
|
|
Drug combination with theobromine and its use in therapy
|
|
AU2015201844A1
|
|
Therapeutic Combinations of Theobromine and an Antihistamine
|
|
AU2015200651A1
|
|
Theobromine in combination with an expectorant or a mucolytic for use in therapy
|
|
AU2015200654A1
|
|
Combination of theobromine with a decongestant and its use for the treatment of cough
|
|
US2014256752A1
|
|
Drug combinations and uses in treating a coughing condition
|
|
US2014256750A1
|
|
Drug combinations and uses in treating a coughing condition
|
|
US2014256751A1
|
|
Drug combinations and uses in treating a coughing condition
|
|
US2014128354A1
|
|
Compositions and methods for treating inflammatory pain
|
|
US2014155485A1
|
|
Compositions for treating chronic inflammation and inflammatory diseases
|
|
US2014128353A1
|
|
Solid solution compositions and use in cardiovascular disease
|
|
US2014162988A1
|
|
Solid solution compositions and use in chronic inflammation
|
|
EP2943183A1
|
|
Compositions and methods for treating severe pain
|
|
US2014162987A1
|
|
Solid solution compositions and use in severe pain
|
